Literature DB >> 11389735

Cell surface human alpha-L-fucosidase.

O J Cordero1, A Merino, M Páez de la Cadena, B Bugía, M Nogueira, J E Viñuela, V S Martínez-Zorzano, A de Carlos, F J Rodríguez-Berrocal.   

Abstract

The acid alpha-L-fucosidase is usually found as a soluble component of lysosomes where fucoglycoconjugates are degraded. In the present investigation, we have demonstrated the existence of a cell surface protein with enzymatic alpha-L-fucosidase activity that crossreacts specifically with a rabbit anti-(alpha-L-fucosidase) Ig. By different approaches, this alpha-L-fucosidase, which represents 10-20% of the total cellular fucosidase activity, was detected in all the tested human cells (hemopoietic, epithelial, mesenchymal). Two bands of approximately 43-49 kDa were observed, although theoretical data support the possibility of having the same genetic origin that the known 50 to 55-kDa Mr alpha-L-fucosidase. We speculate about an alternative traffic pathway for the plasma membrane alpha-L-fucosidase to work on the rapid turnover of glycoproteins.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11389735     DOI: 10.1046/j.1432-1327.2001.02237.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  10 in total

1.  Β-hexosaminidase over-expression affects lysosomal glycohydrolases expression and glycosphingolipid metabolism in mammalian cells.

Authors:  Brunella Tancini; Alessandro Magini; Barbara Bortot; Alice Polchi; Lorena Urbanelli; Sandro Sonnino; Giovanni Maria Severini; Carla Emiliani
Journal:  Mol Cell Biochem       Date:  2011-12-07       Impact factor: 3.396

2.  Evaluation of squamous cell carcinoma antigen-immunoglobulin M complex (SCCA-IGM) and alpha-L-fucosidase (AFU) as novel diagnostic biomarkers for hepatocellular carcinoma.

Authors:  Nehad A Mossad; Enas H Mahmoud; Enas A Osman; Sherif H Mahmoud; Hend I Shousha
Journal:  Tumour Biol       Date:  2014-08-17

3.  Leukocyte extravasation: an immunoregulatory role for alpha-L-fucosidase?

Authors:  Simi Ali; Yvonne Jenkins; Maureen Kirkley; Athanasios Dagkalis; Ayyakkannu Manivannan; Isabel Joan Crane; John A Kirby
Journal:  J Immunol       Date:  2008-08-15       Impact factor: 5.422

4.  Mutation identification and characterization of a Taiwanese patient with fucosidosis.

Authors:  Shuan-Pei Lin; Jui-Hung Chang; Maria Paez de la Cadena; Ting-Fang Chang; Guey-Jen Lee-Chen
Journal:  J Hum Genet       Date:  2007-04-11       Impact factor: 3.172

5.  Impact of isotype-selective estrogen receptor agonists on ovarian function.

Authors:  Christa Hegele-Hartung; Philip Siebel; Olaf Peters; Dirk Kosemund; Gerd Müller; Alexander Hillisch; Alexander Walter; Jörn Kraetzschmar; Karl-Heinrich Fritzemeier
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-22       Impact factor: 11.205

6.  Durable remission of renal cell carcinoma in conjuncture with graft versus host disease following allogeneic stem cell transplantation and donor lymphocyte infusion: rule or exception?

Authors:  Cornelis A M van Bergen; Elisabeth M E Verdegaal; M Wilhelmina Honders; Conny Hoogstraten; A Q M Jeanne Steijn-van Tol; Linda de Quartel; Joan de Jong; Maaike Meyering; J H Frederik Falkenburg; Marieke Griffioen; Susanne Osanto
Journal:  PLoS One       Date:  2014-01-15       Impact factor: 3.240

7.  Genome-Wide Analysis Identifies IL-18 and FUCA2 as Novel Genes Associated with Diastolic Function in African Americans with Sickle Cell Disease.

Authors:  Julio D Duarte; Ankit A Desai; Justin R Sysol; Taimur Abbasi; Amit R Patel; Roberto M Lang; Akash Gupta; Joe G N Garcia; Victor R Gordeuk; Roberto F Machado
Journal:  PLoS One       Date:  2016-09-16       Impact factor: 3.240

8.  Human a-L-fucosidase-1 attenuates the invasive properties of thyroid cancer.

Authors:  Giancarlo Vecchio; Alessia Parascandolo; Chiara Allocca; Clara Ugolini; Fulvio Basolo; Marco Moracci; Andrea Strazzulli; Beatrice Cobucci-Ponzano; Mikko O Laukkanen; Maria Domenica Castellone; Nobuo Tsuchida
Journal:  Oncotarget       Date:  2017-04-18

9.  FUCA2 Is a Prognostic Biomarker and Correlated With an Immunosuppressive Microenvironment in Pan-Cancer.

Authors:  Anyuan Zhong; Ting Chen; Yufei Xing; Xue Pan; Minhua Shi
Journal:  Front Immunol       Date:  2021-10-20       Impact factor: 7.561

Review 10.  Dual role of fucosidase in cancers and its clinical potential.

Authors:  Jinxing Fu; Qing Guo; Yuan Feng; Peng Cheng; Anhua Wu
Journal:  J Cancer       Date:  2022-08-15       Impact factor: 4.478

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.